vs
Side-by-side financial comparison of BeOne Medicines Ltd. (ONC) and RANGE RESOURCES CORP (RRC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $786.9M, roughly 1.9× RANGE RESOURCES CORP). RANGE RESOURCES CORP runs the higher net margin — 22.8% vs 4.4%, a 18.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 18.0%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 14.6%).
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Range Resources Corporation is a natural gas exploration and production company, the headquartered is in Fort Worth, Texas. It operates in the Marcellus Formation, where it is the largest land owners.
ONC vs RRC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $786.9M |
| Net Profit | $66.5M | $179.1M |
| Gross Margin | 90.5% | 94.5% |
| Operating Margin | 12.4% | — |
| Net Margin | 4.4% | 22.8% |
| Revenue YoY | 32.8% | 18.0% |
| Net Profit YoY | 143.8% | 88.8% |
| EPS (diluted) | $0.05 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $786.9M | ||
| Q3 25 | $1.4B | $655.3M | ||
| Q2 25 | $1.3B | $699.6M | ||
| Q1 25 | $1.1B | $846.3M | ||
| Q4 24 | $1.1B | $667.0M | ||
| Q3 24 | $1.0B | $567.9M | ||
| Q2 24 | $929.2M | $513.2M | ||
| Q1 24 | $751.7M | $598.8M |
| Q4 25 | $66.5M | $179.1M | ||
| Q3 25 | $124.8M | $144.3M | ||
| Q2 25 | $94.3M | $237.6M | ||
| Q1 25 | $1.3M | $97.1M | ||
| Q4 24 | $-151.9M | $94.8M | ||
| Q3 24 | $-121.3M | $50.7M | ||
| Q2 24 | $-120.4M | $28.7M | ||
| Q1 24 | $-251.2M | $92.1M |
| Q4 25 | 90.5% | 94.5% | ||
| Q3 25 | 86.1% | 92.5% | ||
| Q2 25 | 87.5% | 95.0% | ||
| Q1 25 | 85.2% | 93.1% | ||
| Q4 24 | 85.8% | 93.7% | ||
| Q3 24 | 83.0% | 94.3% | ||
| Q2 24 | 85.1% | 93.4% | ||
| Q1 24 | 83.4% | 94.7% |
| Q4 25 | 12.4% | — | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | -7.0% | — | ||
| Q3 24 | -12.0% | — | ||
| Q2 24 | -11.5% | — | ||
| Q1 24 | -34.8% | — |
| Q4 25 | 4.4% | 22.8% | ||
| Q3 25 | 8.8% | 22.0% | ||
| Q2 25 | 7.2% | 34.0% | ||
| Q1 25 | 0.1% | 11.5% | ||
| Q4 24 | -13.5% | 14.2% | ||
| Q3 24 | -12.1% | 8.9% | ||
| Q2 24 | -13.0% | 5.6% | ||
| Q1 24 | -33.4% | 15.4% |
| Q4 25 | $0.05 | $0.75 | ||
| Q3 25 | $0.08 | $0.60 | ||
| Q2 25 | $0.06 | $0.99 | ||
| Q1 25 | $0.00 | $0.40 | ||
| Q4 24 | $-0.10 | $0.38 | ||
| Q3 24 | $-0.09 | $0.21 | ||
| Q2 24 | $-0.09 | $0.12 | ||
| Q1 24 | $-0.19 | $0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | $204.0K |
| Total DebtLower is stronger | $836.4M | $1.2B |
| Stockholders' EquityBook value | $4.4B | $4.3B |
| Total Assets | $8.2B | $7.4B |
| Debt / EquityLower = less leverage | 0.19× | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.5B | $204.0K | ||
| Q3 25 | $4.0B | $175.0K | ||
| Q2 25 | $2.8B | $134.0K | ||
| Q1 25 | $2.5B | $344.6M | ||
| Q4 24 | $2.6B | $304.5M | ||
| Q3 24 | $2.7B | $277.4M | ||
| Q2 24 | $2.6B | $251.1M | ||
| Q1 24 | $2.8B | $343.1M |
| Q4 25 | $836.4M | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
| Q4 25 | $4.4B | $4.3B | ||
| Q3 25 | $4.1B | $4.2B | ||
| Q2 25 | $3.8B | $4.1B | ||
| Q1 25 | $3.5B | $3.9B | ||
| Q4 24 | $3.3B | $3.9B | ||
| Q3 24 | $3.4B | $3.9B | ||
| Q2 24 | $3.4B | $3.9B | ||
| Q1 24 | $3.4B | $3.8B |
| Q4 25 | $8.2B | $7.4B | ||
| Q3 25 | $7.6B | $7.2B | ||
| Q2 25 | $6.3B | $7.1B | ||
| Q1 25 | $5.8B | $7.4B | ||
| Q4 24 | $5.9B | $7.3B | ||
| Q3 24 | $5.8B | $7.2B | ||
| Q2 24 | $5.7B | $7.3B | ||
| Q1 24 | $5.7B | $7.4B |
| Q4 25 | 0.19× | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $417.3M | $257.5M |
| Free Cash FlowOCF − Capex | $379.8M | — |
| FCF MarginFCF / Revenue | 25.4% | — |
| Capex IntensityCapex / Revenue | 2.5% | — |
| Cash ConversionOCF / Net Profit | 6.28× | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | $941.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $417.3M | $257.5M | ||
| Q3 25 | $402.6M | $247.5M | ||
| Q2 25 | $263.6M | $336.2M | ||
| Q1 25 | $44.1M | $330.1M | ||
| Q4 24 | $75.2M | $217.9M | ||
| Q3 24 | $188.4M | $245.9M | ||
| Q2 24 | $-95.6M | $148.8M | ||
| Q1 24 | $-308.6M | $331.9M |
| Q4 25 | $379.8M | — | ||
| Q3 25 | $354.5M | — | ||
| Q2 25 | $219.8M | — | ||
| Q1 25 | $-12.3M | — | ||
| Q4 24 | $-17.3M | — | ||
| Q3 24 | $54.7M | — | ||
| Q2 24 | $-205.5M | — | ||
| Q1 24 | $-465.1M | — |
| Q4 25 | 25.4% | — | ||
| Q3 25 | 25.1% | — | ||
| Q2 25 | 16.7% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | -1.5% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | -22.1% | — | ||
| Q1 24 | -61.9% | — |
| Q4 25 | 2.5% | — | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 13.3% | — | ||
| Q2 24 | 11.8% | — | ||
| Q1 24 | 20.8% | — |
| Q4 25 | 6.28× | 1.44× | ||
| Q3 25 | 3.22× | 1.72× | ||
| Q2 25 | 2.79× | 1.42× | ||
| Q1 25 | 34.71× | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 4.85× | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | — | 3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ONC
Segment breakdown not available.
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
